SpotDraft, a contract lifecycle management platform with AI-powered features, has raised $54 million in a new funding round.
AbbVie and Xilio Therapeutics have inked a collaboration and option-to-license agreement potentially worth more than $2 billion to clinical-stage biotechnology company Xilio.
Golden Ocean Group Limited (NASDAQ/OSE: GOGL) (the “Company”) announces that it has declared the purchase options for eight Capesize vessels ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results